
CareTrust REIT demonstrates robust FFO-per-share growth, raised 2026 guidance, and aggressive investment activity, supporting a Buy rating despite premium valuation. Q2 2026 results show normalized FF

CareTrust REIT is upgraded to 'Buy' after a price pullback, offering a rare blend of yield and high growth. CTRE's diversified platform, robust pipeline, and focus on quality operators underpin 16% FF
CareTrust REIT NYSE: CTRE reported record second-quarter investment activity and raised its full-year 2026 guidance, citing continued deal flow across U.S. skilled nursing, U.K. care homes, senior hou